Jorge DiMartino
Director/Board Member bij Gotham Therapeutics Corp.
Vermogen: 327 856 $ op 29-02-2024
Profiel
Jorge DiMartino is on the board of Gotham Therapeutics Corp.
In his past career Dr. DiMartino occupied the position of Chief Medical Officer & EVP-Clinical Development at Kronos Bio, Inc., Group Medical Director at Genentech, Inc. and Vice President-Translational Development Oncology at Celgene Corp.
Dr. DiMartino received a doctorate from Cornell University Graduate School and a doctorate from the University of California San Diego.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
KRONOS BIO INC
0.54% | 04-01-2024 | 315 246 ( 0.54% ) | 327 856 $ | 29-02-2024 |
Actieve functies van Jorge DiMartino
Bedrijven | Functie | Begin |
---|---|---|
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Director/Board Member | - |
Eerdere bekende functies van Jorge DiMartino
Bedrijven | Functie | Einde |
---|---|---|
KRONOS BIO, INC. | Chief Tech/Sci/R&D Officer | 16-02-2024 |
CELGENE | Corporate Officer/Principal | 01-12-2019 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Jorge DiMartino
University of California San Diego | Doctorate Degree |
Cornell University Graduate School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
KRONOS BIO, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Health Technology |